demant

Demant Releases 2021 Interim Financial Report

KONGEBAKKEN, DENMARK — Demant A/S announced the release of its 2021 Interim Report this week. The company reported organic growth of 51% in the first half (H1) of the year, and market share gains in Hearing Healthcare. The recovery in the global hearing healthcare market for H1 was in line with expectations. EBIT of DKK 1,638 million…

Read More

Oticon Medical Announces FDA Premarket Approval for Neuro Cochlear Implant System

SOMERSET, NEW JERSEY — Oticon Medical today announced that the US Food and Drug Administration (FDA) has granted premarket approval (PMA) to the company’s Neuro System to treat individuals 18 years or older, with bilateral severe-to-profound sensorineural hearing loss, who obtain limited benefit from appropriately fitted hearing aid(s). With the expansion of its cochlear implant…

Read More
bone anchored awareness day

First Ever Bone Anchored Awareness Day Set for May 3rd

Oticon Medical is launching an annual recurring awareness day, Good Vibrations Day, to celebrate and raise awareness about bone anchored hearing as a treatment. Today, more than 250,000 people from all over the globe use some form of bone conduction hearing device. May 3 is meant to celebrate them and the treatment—regardless of brand—by providing…

Read More
oticon medical blog

Oticon Medical Launches New Blog for Hearing Healthcare and Medical Professionals

Oticon Medical has announced the launch of its new blog, Hearing Implant Updates for Professionals. The blog has been designed as an added way to engage Oticon Medical’s current and potential professional customers, and will provide topics of interest for hearing healthcare professionals and other medical professionals who wish to learn more about hearing implant…

Read More
oticon medical us president

John Sparacio Named President of Oticon Medical US

SOMERSET, NEW JERSEY — Oticon Medical US announced that it has named John Sparacio as President. In his new role, Sparacio will be responsible for leading the organization and advancing the company’s position in bone anchored hearing systems and cochlear implant solutions in the US market. He will report directly to Mikael Worning, President of…

Read More

CMS backs down; will preserve Medicare coverage of bone-anchored hearing systems

By David H. Kirkwood WASHINGTON, DC—Responding to a broad-based national campaign by manufacturers, hearing care providers, and consumer advocates, the Centers for Medicare and Medicaid Services (CMS) announced on October 31 that it had reversed its position and would not end Medicare coverage of auditory osseointegrated implants (AOIs). As previously reported on this blog, CMS…

Read More